Elevated IL-1β levels appear to play a pivotal role in MS pathophysiology by activating microglia and astrocytes, disrupting the BBB, recruiting peripheral immune cells, and exacerbating demyelination and neuronal damage through the promotion of reactive T-cell responses. Here, IL1B is linked to myeloid sarcoma.